Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vicente, Estrada Pérez"'
Autor:
Anabel Franco-Moreno, María Soledad Acedo-Gutiérrez, Nicolás Labrador-San Martín, Clara Hernández-Blanco, Celia Rodríguez-Olleros, Fátima Ibáñez-Estéllez, Ana Suárez-Simón, Mateo Balado-Rico, Ana Rocío Romero-Paternina, David Alonso-Menchén, Belén Escolano-Fernández, Esther Piniella-Ruiz, Ester Alonso-Monge, Helena Notario-Leo, Carlos Bibiano-Guillén, Gabriela Peña-Lillo, Armando Antiqueira-Pérez, Rodolfo Romero-Pareja, Noemí Cabello-Clotet, Vicente Estrada-Pérez, Jesús Troya-García, María de Carranza-López, Ismael Escobar-Rodríguez, Nacho Vallejo-Maroto, Juan Torres-Macho
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Corticosteroids are one of the few drugs that have shown a reduction in mortality in coronavirus disease 2019 (COVID-19). In the RECOVERY trial, the use of dexamethasone reduced 28-day mortality compared to standard care in hospit
Externí odkaz:
https://doaj.org/article/70c226fc671044838f447823d98062bf
Autor:
Oskar Ayerdi Aguirrebengoa, Mar Vera García, Daniel Arias Ramírez, Natalia Gil García, Teresa Puerta López, Petunia Clavo Escribano, Juan Ballesteros Martín, Clara Lejarraga Cañas, Nuria Fernandez Piñeiro, Manuel Enrique Fuentes Ferrer, Mónica García Lotero, Estefanía Hurtado Gallegos, Montserrat Raposo Utrilla, Vicente Estrada Pérez, Jorge Del Romero Guerrero, Carmen Rodríguez Martín
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0245925 (2021)
ObjectiveSince the recent introduction of preexposure prophylaxis (PrEP), several studies have reported a decrease in the use of condoms and a rise in STIs among users. This rise in risk behavior associated with the advent of PrEP is known as "risk c
Externí odkaz:
https://doaj.org/article/0221a7539a354c58bc56773372f4fc08
Autor:
Juan, González Del Castillo, Manuel Enrique, Fuentes Ferrer, Cristina, Fernández Pérez, Germán, Molina Romera, María José, Núñez Orantos, Vicente, Estrada Pérez
Publikováno v:
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias. 34(3)
The rates of undiagnosed and late-diagnosed human immunodeficiency virus (HIV) infection are high. Screening for HIV infection in hospital emergency departments (EDs) could offer a way to increase the number of diagnoses. Our aim was to analyze wheth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b05ed1d3dd23e1b6054998cc243986df
https://pubmed.ncbi.nlm.nih.gov/35736525
https://pubmed.ncbi.nlm.nih.gov/35736525
Autor:
Anabel Franco-Moreno, María Soledad Acedo-Gutiérrez, Nicolás Labrador-San Martín, Clara Hernández-Blanco, Celia Rodríguez-Olleros, Fátima Ibáñez-Estéllez, Ana Suárez-Simón, Mateo Balado-Rico, Ana Rocío Romero-Paternina, David Alonso-Menchén, Belén Escolano-Fernández, Esther Piniella-Ruiz, Ester Alonso-Monge, Helena Notario-Leo, Carlos Bibiano-Guillén, Gabriela Peña-Lillo, Armando Antiqueira-Pérez, Rodolfo Romero-Pareja, Noemí Cabello-Clotet, Vicente Estrada-Pérez, Jesús Troya-García, María de Carranza-López, Ismael Escobar-Rodríguez, Nacho Vallejo-Maroto, Juan Torres-Macho
Publikováno v:
Trials. 23(1)
Background Corticosteroids are one of the few drugs that have shown a reduction in mortality in coronavirus disease 2019 (COVID-19). In the RECOVERY trial, the use of dexamethasone reduced 28-day mortality compared to standard care in hospitalized pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::158f1553e4cae5964c219a76e1b97d99
https://pubmed.ncbi.nlm.nih.gov/36109825
https://pubmed.ncbi.nlm.nih.gov/36109825
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 27:27-31
Etravirine (ETR) belongs to the family of non-nucleoside analogue reverse transcriptase inhibitors (NNRTIs), with antiviral activity in patients with resistance to first-generation NNRTIs. The drug interactions caused by ETR are due to its dual effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44ae181f82b13995ffc6eb49691a3fca
https://doi.org/10.1016/s0213-005x(09)73216-1
https://doi.org/10.1016/s0213-005x(09)73216-1
Publikováno v:
Enfermedades infecciosas y microbiologia clinica. 27
Etravirine (ETR) belongs to the family of non-nucleoside analogue reverse transcriptase inhibitors (NNRTIs), with antiviral activity in patients with resistance to first-generation NNRTIs. The drug interactions caused by ETR are due to its dual effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c44c623458dee717b551b9d1ffa95951
https://pubmed.ncbi.nlm.nih.gov/20116625
https://pubmed.ncbi.nlm.nih.gov/20116625